| scholarly article | Q13442814 |
| P2093 | author name string | Huali Xu | |
| E Shyam P Reddy | |||
| Veena N Rao | |||
| Chunshu Yang | |||
| Kunchala Rungsrisuriyachai | |||
| Jinbo Fang | |||
| Sharif Morsalin | |||
| Shubhalaxmi Kayarthodi | |||
| Brittany Mckenzie | |||
| Ujwala Gunnal | |||
| P2860 | cites work | The erg gene: a human gene related to the ets oncogene | Q24299030 |
| The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains | Q24319886 | ||
| Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins | Q24633428 | ||
| Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. | Q27824849 | ||
| Mechanisms of TGF-beta signaling from cell membrane to the nucleus | Q27860785 | ||
| Role of transforming growth factor-beta signaling in cancer | Q28145449 | ||
| Smad-dependent and Smad-independent pathways in TGF-beta family signalling | Q28208250 | ||
| erg, an ets-related gene, codes for sequence-specific transcriptional activators | Q28238746 | ||
| TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain | Q28241486 | ||
| Characterization of the DNA binding and transcriptional activation domains of the erg protein | Q28270082 | ||
| TGF-β family signaling in stem cells | Q28274611 | ||
| TGFβ signalling in context | Q28275410 | ||
| The human erg gene maps to chromosome 21, band q22: relationship to the 8; 21 translocation of acute myelogenous leukemia | Q28294400 | ||
| erg, a human ets-related gene on chromosome 21: alternative splicing, polyadenylation, and translation | Q28295357 | ||
| Specificity and versatility in tgf-beta signaling through Smads | Q29616324 | ||
| Delineation of TMPRSS2-ERG splice variants in prostate cancer | Q33357287 | ||
| Role of TMPRSS2-ERG gene fusion in negative regulation of PSMA expression | Q33952306 | ||
| Use of a TGFβ type I receptor inhibitor in mouse skin carcinogenesis reveals a dual role for TGFβ signaling in tumor promotion and progression | Q34363852 | ||
| Transforming growth factor-beta signal transduction in epithelial cells. | Q34438032 | ||
| A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers. | Q34768457 | ||
| Transforming growth factor-β and the hallmarks of cancer | Q34789300 | ||
| Oncogenic activation of ERG: A predominant mechanism in prostate cancer | Q35685920 | ||
| Phospho-specific Smad3 signaling: impact on breast oncogenesis | Q36116217 | ||
| A causal role for ERG in neoplastic transformation of prostate epithelium. | Q36883091 | ||
| The discovery of common recurrent transmembrane protease serine 2 (TMPRSS2)-erythroblastosis virus E26 transforming sequence (ETS) gene fusions in prostate cancer: significance and clinical implications | Q37460610 | ||
| Molecular Mechanism of Activation of Transforming Growth Factor Beta/Smads Signaling Pathway in Ets Related Gene-Positive Prostate Cancers | Q38301071 | ||
| Anti-Epileptic Drug Targets Ewing Sarcoma | Q38301170 | ||
| Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells | Q38335697 | ||
| Increased TGF-β1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signaling | Q39415532 | ||
| SMAD3 is essential for transforming growth factor-β1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytes | Q39498984 | ||
| Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer | Q40038137 | ||
| ETS gene fusions and prostate cancer | Q42064904 | ||
| Monoallelic expression of TMPRSS2/ERG in prostate cancer stem cells | Q44287808 | ||
| Detection and clinical significance of gene rearrangements in Chinese patients with adult acute lymphoblastic leukemia | Q46091599 | ||
| Promotion and maintenance of leukemia by ERG. | Q53268059 | ||
| P433 | issue | 3 | |
| P921 | main subject | collaboration | Q1145523 |
| P304 | page(s) | 175-181 | |
| P577 | publication date | 2014-09-01 | |
| P1433 | published in | Journal of pharmaceutical sciences and pharmacology | Q27726023 |
| P1476 | title | Ets Related Gene and Smad3 Proteins Collaborate to Activate Transforming Growth Factor-Beta Mediated Signaling Pathway in ETS Related Gene-Positive Prostate Cancer Cells | |
| P478 | volume | 1 |
| Q42375998 | Dynamic regulation of canonical TGFβ signalling by endothelial transcription factor ERG protects from liver fibrogenesis |
| Q41446090 | Molecular Mechanism of β-Catenin Signaling Pathway Inactivation in ETV1-Positive Prostate Cancers |
| Q50139666 | Novel EWSR1-SMAD3 Gene Fusions in a Group of Acral Fibroblastic Spindle Cell Neoplasms |
| Q64906050 | Relationship between ETS Transcription Factor ETV1 and TGF-β-regulated SMAD Proteins in Prostate Cancer. |
| Q52584365 | The role and gene expression profile of SOCS3 in colorectal carcinoma. |
| Q41478244 | Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer |
Search more.